Healthcare
State Administration for Market Regulation, Compliance Guidelines for Pharmaceutical Enterprises to Guard Against Commercial Bribery Risks
国家市场监督管理总局医药企业防范商业贿赂风险合规指引
Where a pharmaceutical enterprise engages a medical or healthcare worker to provide consulting services, it shall pay attention to identifying and guarding against the risks associated with the following acts:
(1) it shall avoid paying the service fee to the medical or healthcare work in the form of cash or a cash equivalent;
(2) it is prohibited from encouraging or inducing the medical or healthcare worker it has engaged to provide relevant consulting services to write pharmaceutical prescriptions or to recommend, publicize, procure or use the enterprise’s pharmaceuticals; and
(3) it is prohibited, in the guise of consulting services, from funneling improper benefits to the medical or healthcare worker.